Status:
TERMINATED
AR US Versus sUS or Fluoroscopic Injections for Shoulder Punction
Lead Sponsor:
Balgrist University Hospital
Conditions:
Ultrasound
Interventions
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to prospectively evaluate the potential benefits of injections with Augmented Reality enhanced Ulrasound versus standard Ultrasound or fluoroscopy participants where...
Detailed Description
Patients assigned for standard Ultrasound or fluoroscopic joint injection are informed about the trial. Participants are randomly assigned to the study or control intervention. 1:1 randomization is us...
Eligibility Criteria
Inclusion
- \- Patients 18 to 99 years of age
- Patients assigned for fluoroscopic guided injections (including MR arthrographies)
- Patients assigned for US guided injections (including MR arthrographies)
Exclusion
- \- Patients who are not willing to be part of the study
- Contraindication against fluoroscopic guided injection
- Women who are pregnant or breast feeding (Pregnancy assessment is part of the routine prior to fluoroscopic joint injections. No pregnancy test will be done for this study.)
Key Trial Info
Start Date :
June 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT06053892
Start Date
June 13 2023
End Date
January 31 2025
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8008